Literature DB >> 17037597

SARS coronavirus vaccine development.

Ralph S Baric1, Timothy Sheahan, Damon Deming, Eric Donaldson, Boyd Yount, Amy C Sims, Rhonda S Roberts, Matthew Frieman, Barry Rockx.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17037597      PMCID: PMC7124095          DOI: 10.1007/978-0-387-33012-9_101

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  22 in total

1.  Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template.

Authors:  Jeronimo Cello; Aniko V Paul; Eckard Wimmer
Journal:  Science       Date:  2002-07-11       Impact factor: 47.728

2.  Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China.

Authors: 
Journal:  Science       Date:  2004-01-29       Impact factor: 47.728

Review 3.  Human immunosenescence: is it infectious?

Authors:  Graham Pawelec; Arne Akbar; Calogero Caruso; Rafael Solana; Beatrix Grubeck-Loebenstein; Anders Wikby
Journal:  Immunol Rev       Date:  2005-06       Impact factor: 12.988

4.  Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms.

Authors:  Biao Kan; Ming Wang; Huaiqi Jing; Huifang Xu; Xiugao Jiang; Meiying Yan; Weili Liang; Han Zheng; Kanglin Wan; Qiyong Liu; Buyun Cui; Yanmei Xu; Enmin Zhang; Hongxia Wang; Jingrong Ye; Guichang Li; Machao Li; Zhigang Cui; Xiaobao Qi; Kai Chen; Lin Du; Kai Gao; Yu-Teng Zhao; Xiao-Zhong Zou; Yue-Ju Feng; Yu-Fan Gao; Rong Hai; Dongzhen Yu; Yi Guan; Jianguo Xu
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

5.  Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans.

Authors:  Anjeanette Roberts; Christopher Paddock; Leatrice Vogel; Emily Butler; Sherif Zaki; Kanta Subbarao
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

6.  Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets.

Authors:  Hana Weingartl; Markus Czub; Stefanie Czub; James Neufeld; Peter Marszal; Jason Gren; Greg Smith; Shane Jones; Roxanne Proulx; Yvonne Deschambault; Elsie Grudeski; Anton Andonov; Runtao He; Yan Li; John Copps; Allen Grolla; Daryl Dick; Jody Berry; Shelley Ganske; Lisa Manning; Jingxin Cao
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

7.  Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus.

Authors:  Boyd Yount; Kristopher M Curtis; Elizabeth A Fritz; Lisa E Hensley; Peter B Jahrling; Erik Prentice; Mark R Denison; Thomas W Geisbert; Ralph S Baric
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-20       Impact factor: 11.205

Review 8.  SARS vaccine development.

Authors:  Shibo Jiang; Yuxian He; Shuwen Liu
Journal:  Emerg Infect Dis       Date:  2005-07       Impact factor: 6.883

9.  Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of severe acute respiratory syndrome coronavirus (SARS-CoV).

Authors:  Szu-Chia Lai; Pele Choi-Sing Chong; Chia-Tsui Yeh; Levent Shih-Jen Liu; Jia-Tsrong Jan; Hsiang-Yun Chi; Hwan-Wun Liu; Ann Chen; Yeau-Ching Wang
Journal:  J Biomed Sci       Date:  2005-11-09       Impact factor: 8.410

10.  Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.

Authors:  Wenhui Li; Michael J Moore; Natalya Vasilieva; Jianhua Sui; Swee Kee Wong; Michael A Berne; Mohan Somasundaran; John L Sullivan; Katherine Luzuriaga; Thomas C Greenough; Hyeryun Choe; Michael Farzan
Journal:  Nature       Date:  2003-11-27       Impact factor: 49.962

View more
  8 in total

1.  Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirus.

Authors:  Timothy Sheahan; Alan Whitmore; Kristin Long; Martin Ferris; Barry Rockx; William Funkhouser; Eric Donaldson; Lisa Gralinski; Martha Collier; Mark Heise; Nancy Davis; Robert Johnston; Ralph S Baric
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

2.  Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge.

Authors:  Barry Rockx; Davide Corti; Eric Donaldson; Timothy Sheahan; Konrad Stadler; Antonio Lanzavecchia; Ralph Baric
Journal:  J Virol       Date:  2008-01-16       Impact factor: 5.103

Review 3.  Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection.

Authors:  Vincent C C Cheng; Susanna K P Lau; Patrick C Y Woo; Kwok Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

4.  Synthetic reconstruction of zoonotic and early human severe acute respiratory syndrome coronavirus isolates that produce fatal disease in aged mice.

Authors:  Barry Rockx; Timothy Sheahan; Eric Donaldson; Jack Harkema; Amy Sims; Mark Heise; Raymond Pickles; Mark Cameron; David Kelvin; Ralph Baric
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

5.  Development of a chimeric DNA-RNA hammerhead ribozyme targeting SARS virus.

Authors:  Akiko Fukushima; Noboru Fukuda; Yimu Lai; Takahiro Ueno; Mitsuhiko Moriyama; Fumihiro Taguchi; Akifumi Iguchi; Kazushi Shimizu; Kazumichi Kuroda
Journal:  Intervirology       Date:  2009-05-07       Impact factor: 1.763

Review 6.  A decade after SARS: strategies for controlling emerging coronaviruses.

Authors:  Rachel L Graham; Eric F Donaldson; Ralph S Baric
Journal:  Nat Rev Microbiol       Date:  2013-11-11       Impact factor: 60.633

7.  Systematic assembly and genetic manipulation of the mouse hepatitis virus A59 genome.

Authors:  Eric F Donaldson; Amy C Sims; Ralph S Baric
Journal:  Methods Mol Biol       Date:  2008

8.  The Impact of COVID-19 on the Insurance Industry.

Authors:  Pius Babuna; Xiaohua Yang; Amatus Gyilbag; Doris Abra Awudi; David Ngmenbelle; Dehui Bian
Journal:  Int J Environ Res Public Health       Date:  2020-08-10       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.